Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Cancer cachexia syndrome (CCS) is a multifactorial metabolic syndrome affecting a significant proportion of patients. CCS is characterized by progressive weight loss, alterations of body composition and a systemic inflammatory status, which exerts a major impact on the host’s innate and adaptive imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Rounis, Konstantinos, Makrakis, Dimitrios, Gioulbasanis, Ioannis, Ekman, Simon, De Petris, Luigi, Mavroudis, Dimitris, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225288/
https://www.ncbi.nlm.nih.gov/pubmed/35743911
http://dx.doi.org/10.3390/life12060880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225288/
https://www.ncbi.nlm.nih.gov/pubmed/35743911
http://dx.doi.org/10.3390/life12060880

Ejemplares similares